The University of Chicago Header Logo

Connection

Dejan Micic to Liver

This is a "connection" page, showing publications Dejan Micic has written about Liver.
Connection Strength

1.398
  1. Teduglutide improves liver chemistries in short bowel syndrome-associated intestinal failure: Post hoc analysis. Nutr Clin Pract. 2024 Jun; 39(3):634-640.
    View in: PubMed
    Score: 0.655
  2. Hiding in the Water. N Engl J Med. 2020 May 07; 382(19):1844-1849.
    View in: PubMed
    Score: 0.501
  3. Evaluation of the fibrosis-4 index for detection of advanced fibrosis among individuals at risk for intestinal failure-associated liver disease. JPEN J Parenter Enteral Nutr. 2022 03; 46(3):678-684.
    View in: PubMed
    Score: 0.135
  4. Vedolizumab in patients with concurrent primary sclerosing cholangitis and inflammatory bowel disease does not improve liver biochemistry but is safe and effective for the bowel disease. Aliment Pharmacol Ther. 2018 Mar; 47(6):753-762.
    View in: PubMed
    Score: 0.107
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.